Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.

ABSTRACT:

Background

Worldwide, respiratory syncytial virus (RSV) is considered to be the most important viral cause of respiratory morbidity and mortality among infants and young children. Although no active vaccine is available on the market yet, there are several active vaccine development programs in various stages. To assess whether one of these vaccines might be a future asset for national immunization programs, modeling the costs and benefits of various vaccination strategies is needed.

Objectives

To evaluate the potential cost-effectiveness of RSV vaccination of infants and/or pregnant women in Turkey.

Methods

A multi-cohort static Markov model with cycles of one month was used to compare the cost-effectiveness of vaccinated cohorts versus non-vaccinated cohorts. The 20

SUBMITTER: Pouwels KB 

PROVIDER: S-EPMC5045176 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature